| Year |
Citation |
Score |
| 2022 |
Qin Y, Dinabandhu A, Cao X, Sanchez JC, Jee K, Rodrigues M, Guo C, Zhang J, Vancel J, Menon D, Khan NS, Ma T, Tzeng SY, Daoud YJ, Green JJ, ... ... Montaner S, et al. ANGPTL4 influences the therapeutic response of neovascular age-related macular degeneration patients by promoting choroidal neovascularization. Jci Insight. PMID 35653189 DOI: 10.1172/jci.insight.157896 |
0.385 |
|
| 2022 |
Qin Y, Zhang J, Babapoor-Farrokhran S, Applewhite B, Deshpande M, Megarity H, Flores-Bellver M, Aparicio-Domingo S, Ma T, Rui Y, Tzeng SY, Green JJ, Canto-Soler MV, Montaner S, Sodhi A. PAI-1 is a vascular cell-specific HIF-2-dependent angiogenic factor that promotes retinal neovascularization in diabetic patients. Science Advances. 8: eabm1896. PMID 35235351 DOI: 10.1126/sciadv.abm1896 |
0.376 |
|
| 2021 |
Cao X, Sanchez JC, Dinabandhu A, Guo C, Patel TP, Yang Z, Hu MW, Chen L, Wang Y, Malik D, Jee K, Daoud YJ, Handa JT, Zhang H, Qian J, ... Montaner S, et al. Aqueous proteins help predict the response of neovascular age-related macular degeneration patients to anti-VEGF therapy. The Journal of Clinical Investigation. PMID 34874918 DOI: 10.1172/JCI144469 |
0.31 |
|
| 2019 |
Sodhi A, Ma T, Menon D, Deshpande M, Jee K, Dinabandhu A, Vancel J, Lu D, Montaner S. Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema. The Journal of Clinical Investigation. PMID 31545295 DOI: 10.1172/Jci120879 |
0.493 |
|
| 2017 |
Applewhite BP, Babapoor-Farrokhran S, Poon D, Hassan SJ, Wellmann E, Ying HS, Semenza GL, Montaner S, Sodhi A. Lack of Evidence for Vasoactive and Inflammatory Mediators in the Promotion of Macular Edema Associated with Epiretinal Membranes. Scientific Reports. 7: 10608. PMID 28878218 DOI: 10.1038/S41598-017-08997-6 |
0.351 |
|
| 2017 |
Meng Q, Qin Y, Deshpande M, Kashiwabuchi F, Rodrigues M, Lu Q, Ren H, Elisseeff JH, Semenza GL, Montaner SV, Sodhi A. Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia. Investigative Ophthalmology & Visual Science. 58: 4514-4523. PMID 28873177 DOI: 10.1167/Iovs.17-21974 |
0.422 |
|
| 2017 |
Jee K, Rodrigues M, Kashiwabuchi F, Applewhite BP, Han I, Lutty G, Goldberg MF, Semenza GL, Montaner S, Sodhi A. Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy. Plos One. 12: e0183320. PMID 28832635 DOI: 10.1371/Journal.Pone.0183320 |
0.45 |
|
| 2017 |
Babapoor-Farrokhran S, Poon D, Solomon S, Montaner S, Sodhi A. Expression of angiogenic mediators in a patient with a retinal artery occlusion. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 52: e122-e125. PMID 28774531 DOI: 10.1016/J.Jcjo.2017.01.010 |
0.303 |
|
| 2016 |
Rodrigues M, Kashiwabuchi F, Deshpande M, Jee K, Goldberg MF, Lutty G, Semenza GL, Montaner S, Sodhi A. Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy. Investigative Ophthalmology & Visual Science. 57: 6739-6746. PMID 27951596 DOI: 10.1167/Iovs.16-19513 |
0.419 |
|
| 2016 |
Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, Eberhart CG, Semenza GL, Montaner S, Sodhi A. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. PMID 26761211 DOI: 10.18632/Oncotarget.6868 |
0.505 |
|
| 2015 |
Ma T, Patel H, Babapoor-Farrokhran S, Franklin R, Semenza GL, Sodhi A, Montaner S. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. Angiogenesis. PMID 26092770 DOI: 10.1007/S10456-015-9475-4 |
0.613 |
|
| 2015 |
Babapoor-Farrokhran S, Jee K, Puchner B, Hassan SJ, Xin X, Rodrigues M, Kashiwabuchi F, Ma T, Hu K, Deshpande M, Daoud Y, Solomon S, Wenick A, Lutty GA, Semenza GL, ... Montaner S, et al. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. Proceedings of the National Academy of Sciences of the United States of America. 112: E3030-9. PMID 26039997 DOI: 10.1073/Pnas.1423765112 |
0.458 |
|
| 2013 |
Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S, Wang S, Hu J, Bhutto I, Welsbie DS, Duh EJ, Handa JT, Eberhart CG, Lutty G, Semenza GL, ... Montaner S, et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proceedings of the National Academy of Sciences of the United States of America. 110: E3425-34. PMID 23959876 DOI: 10.1073/Pnas.1217091110 |
0.512 |
|
| 2013 |
Chaisuparat R, Yodsanga S, Montaner S, Jham BC. Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 116: 336-42. PMID 23953418 DOI: 10.1016/J.Oooo.2013.06.013 |
0.71 |
|
| 2013 |
Hsu AW, Sodhi A, Eberhart C, Montaner S, Goldberg MF. Regression of choroidal neovascularization in response to systemic chemotherapy for cancer. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 48: e80-2. PMID 23931490 DOI: 10.1016/J.Jcjo.2013.02.004 |
0.434 |
|
| 2013 |
Rodrigues M, Iliff NT, Eberhart CG, Montaner S, Sodhi A. Scleral penetration of an unusually aggressive case of a retinal hemangioblastoma. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 48: e67-71. PMID 23931485 DOI: 10.1016/J.Jcjo.2013.01.014 |
0.349 |
|
| 2013 |
Rodrigues M, Xin X, Jee K, Babapoor-Farrokhran S, Kashiwabuchi F, Ma T, Bhutto I, Hassan SJ, Daoud Y, Baranano D, Solomon S, Lutty G, Semenza GL, Montaner S, Sodhi A. VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes. 62: 3863-73. PMID 23884892 DOI: 10.2337/Db13-0014 |
0.442 |
|
| 2013 |
Montaner S, Kufareva I, Abagyan R, Gutkind JS. Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. Annual Review of Pharmacology and Toxicology. 53: 331-54. PMID 23092247 DOI: 10.1146/Annurev-Pharmtox-010510-100608 |
0.391 |
|
| 2011 |
Jham BC, Ma T, Hu J, Chaisuparat R, Friedman ER, Pandolfi PP, Schneider A, Sodhi A, Montaner S. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. Plos One. 6: e19103. PMID 21559457 DOI: 10.1371/Journal.Pone.0019103 |
0.783 |
|
| 2011 |
Hu J, Jham BC, Ma T, Friedman ER, Ferreira L, Wright JM, Accurso B, Allen CM, Basile JR, Montaner S. Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma. Oral Oncology. 47: 371-5. PMID 21421336 DOI: 10.1016/J.Oraloncology.2011.02.018 |
0.736 |
|
| 2010 |
Ma T, Jham BC, Hu J, Friedman ER, Basile JR, Molinolo A, Sodhi A, Montaner S. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 107: 14363-8. PMID 20660728 DOI: 10.1073/Pnas.1001065107 |
0.749 |
|
| 2010 |
Jham BC, Montaner S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene. Journal of Cellular Biochemistry. 110: 1-9. PMID 20213674 DOI: 10.1002/Jcb.22524 |
0.717 |
|
| 2010 |
Ma T, Jham BC, Hu J, Friedman ER, Basile JR, Sodhi A, Montaner S. Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A84 |
0.728 |
|
| 2009 |
Montaner S, Chaisuparat R, Hu J, Jham B. AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma Infectious Agents and Cancer. 4: 29. DOI: 10.1186/1750-9378-4-S2-P29 |
0.758 |
|
| 2008 |
Chaisuparat R, Hu J, Jham BC, Knight ZA, Shokat KM, Montaner S. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. Cancer Research. 68: 8361-8. PMID 18922908 DOI: 10.1158/0008-5472.Can-08-0878 |
0.782 |
|
| 2007 |
Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene. 27: 1844-52. PMID 17934524 DOI: 10.1038/Sj.Onc.1210817 |
0.482 |
|
| 2007 |
Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma. Neoplasia (New York, N.Y.). 9: 192-9. PMID 17401459 DOI: 10.1593/Neo.06781 |
0.723 |
|
| 2007 |
Montaner S. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle (Georgetown, Tex.). 6: 438-43. PMID 17329974 DOI: 10.4161/Cc.6.4.3843 |
0.525 |
|
| 2006 |
Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET, Molinolo A, Gutkind JS, Montaner S. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell. 10: 133-43. PMID 16904612 DOI: 10.1016/J.Ccr.2006.05.026 |
0.763 |
|
| 2006 |
Montaner S, Sodhi A, Ramsdell AK, Martin D, Hu J, Sawai ET, Gutkind JS. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Research. 66: 168-74. PMID 16397229 DOI: 10.1158/0008-5472.Can-05-1026 |
0.532 |
|
| 2004 |
Sodhi A, Montaner S, Gutkind JS. Viral hijacking of G-protein-coupled-receptor signalling networks. Nature Reviews. Molecular Cell Biology. 5: 998-1012. PMID 15573137 DOI: 10.1038/Nrm1529 |
0.39 |
|
| 2004 |
Montaner S, Sodhi A, Servitja JM, Ramsdell AK, Barac A, Sawai ET, Gutkind JS. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood. 104: 2903-11. PMID 15231571 DOI: 10.1182/Blood-2003-12-4436 |
0.528 |
|
| 2004 |
Sodhi A, Montaner S, Patel V, Gómez-Román JJ, Li Y, Sausville EA, Sawai ET, Gutkind JS. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 4821-6. PMID 15047889 DOI: 10.1073/Pnas.0400835101 |
0.592 |
|
| 2004 |
Sodhi A, Montaner S, Gutkind JS. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 422-7. PMID 15003988 DOI: 10.1096/Fj.03-1035Hyp |
0.481 |
|
| 2003 |
Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell. 3: 23-36. PMID 12559173 DOI: 10.1016/S1535-6108(02)00237-4 |
0.523 |
|
| 2002 |
Sodhi A, Gutkind JS, Montaner S. The Kaposis Sarcoma Associated Herpesvirus: A model for viral oncogenesis Clinical and Translational Oncology. 4: 118-132. DOI: 10.1007/Bf02732341 |
0.414 |
|
| 2001 |
Sodhi A, Montaner S, Miyazaki H, Gutkind JS. MAPK and akt Act cooperatively but independently on hypoxia inducible factor-1α in rasV12 upregulation of VEGF Biochemical and Biophysical Research Communications. 287: 292-300. PMID 11549290 DOI: 10.1006/Bbrc.2001.5532 |
0.455 |
|
| 1999 |
Montaner S, Perona R, Saniger L, Lacal JC. Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors. The Journal of Biological Chemistry. 274: 8506-15. PMID 10085083 DOI: 10.1074/Jbc.274.13.8506 |
0.325 |
|
| 1998 |
Montaner S, Perona R, Saniger L, Lacal JC. Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases. The Journal of Biological Chemistry. 273: 12779-85. PMID 9582304 DOI: 10.1074/Jbc.273.21.12779 |
0.355 |
|
| 1997 |
Fromm C, Coso OA, Montaner S, Xu N, Gutkind JS. The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation. Proceedings of the National Academy of Sciences of the United States of America. 94: 10098-103. PMID 9294169 DOI: 10.1073/pnas.94.19.10098 |
0.327 |
|
| 1997 |
Perona R, Montaner S, Saniger L, Sánchez-Pérez I, Bravo R, Lacal JC. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes & Development. 11: 463-75. PMID 9042860 DOI: 10.1101/Gad.11.4.463 |
0.391 |
|
| 1995 |
Jiménez B, del Peso L, Montaner S, Esteve P, Lacal JC. Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation. Journal of Cellular Biochemistry. 57: 141-9. PMID 7721953 DOI: 10.1002/Jcb.240570114 |
0.408 |
|
| Show low-probability matches. |